Pharmaceutical companies will have to reveal in detail the payments they make to patient-advocacy groups and professional medical societies in Ontario as part of the province’s efforts to pull back the curtain on money in medicine.

The lack of transparency has meant that health charities and non-profits have had no mandatory obligation to reveal which companies are funding them and in what amounts.

Read more at The Globe and Mail